Policy, Health System, and VBHC Project Support

We equip clients with the knowledge to make informed, impactful decisions.

We support pharmaceutical, biotechnology, medical device, and other health technology companies in demonstrating the value of their products within real healthcare systems. Our work is focused on helping clients generate arguments, evidence, and project concepts that resonate with policy-makers, payers, providers, and other stakeholders involved in access, funding, and adoption decisions.
For many technologies, especially innovative and high-cost solutions, clinical efficacy alone is not sufficient. Decision-makers increasingly expect evidence of system-level relevance: how the technology addresses unmet need, fits treatment pathways, affects resource use, improves patient outcomes, and contributes to broader healthcare objectives. We help clients structure this value story in a way that is credible, evidence-based, and aligned with the priorities of a конкретного market or institution.
This includes support for projects related to value-based healthcare, payment and funding models, patient pathway redesign, policy analysis, and health system positioning. Our goal is to help clients show not only that a technology works, but also why it matters for the healthcare system, for patients, and for those responsible for financing and organizing care.
  • Market research and feasibility studies
  • Competitive landscape and patient journey mapping
  • Provider, payer, patient insights
  • Commercialization and launch strategy
  • Value proposition development for products and solutions

    1

    Other Services

    Clinical Research and Evidence Generation

    We generate the data and insights that drive product development, approval, access, and system integration.

    • Clinical trials (Phase I–III)
    • Post-approval studies (Phase IV, RWE, registries, observational studies)
    • Systematic reviews and meta-analyses
    • Biostatistics, data management, advanced analytics
    • Patient-reported outcomes (PRO), quality of life research
    • Health economics and outcomes research (HEOR)
    • Comparative effectiveness, benefit-risk analysis
    Regulatory Strategy and Market Access

    We help clients navigate regulatory pathways and secure access for:

    • Pharmaceuticals
    • Medical devices
    • In vitro diagnostics
    • Digital health technologies

    Our services include:

    1. Regulatory strategy, dossier preparation, submission
    2. Local adaptation of global registration files
    3. Fast-track, orphan, and early access pathways
    4. Health authority engagement and negotiation
    5. Pricing strategy, cost-effectiveness, budget impact modeling
    6. Reimbursement submissions and negotiation support
    7. Value-based healthcare (VBHC) contracting and outcome-based payment models
    Market Research, Strategy, and Commercial Planning

    We equip clients with the knowledge to make informed, impactful decisions.

    • Market research and feasibility studies
    • Competitive landscape and patient journey mapping
    • Provider, payer, patient insights
    • Commercialization and launch strategy
    • Value proposition development for products and solutions
    Medical Affairs and Stakeholder Engagement

    We help companies build scientific leadership, credibility, and trust.

    • KOL (Key Opinion Leader) identification and engagement
    • Advisory boards, expert panels, and scientific boards
    • Medical writing (protocols, publications, presentations)
    • Scientific communication strategy and materials
    • Medical affairs strategy and training
    • Internal and external education programs
    Special Focus: Pharmaceutical and Medtech Clients

    For pharma, biotech, medtech, diagnostics, and digital health companies, we offer an integrated pathway:

    Clinical development → Market research → Commercial strategy → Regulatory approval → Pricing, HEOR, market access → Policy engagement → VBHC project management → Education, training, and stakeholder support.

    We also help our clients shape the broader healthcare environment — supporting guideline development, payment model design, public health programs, and national health priorities.